Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Elekta AB ( ($SE:EKTA.B) ) just unveiled an update.
Elekta has announced a change in its Nomination Committee ahead of the Annual General Meeting scheduled for September 3, 2026, with Anna Magnusson replacing Thomas Wuolikainen as the Fourth Swedish National Pension Fund’s representative. Following this adjustment, the committee now consists of Chair Laurent Leksell, representing his and related parties’ holdings, along with members appointed by the Fourth Swedish National Pension Fund, Nordea Funds, SEB Funds and Lannebo Kapitalförvaltning, and shareholders have been invited to submit proposals to the committee by early June 2026, underscoring Elekta’s ongoing governance and shareholder engagement processes.
The most recent analyst rating on ($SE:EKTA.B) stock is a Hold with a SEK51.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta AB is a Stockholm-based leader in precision radiation therapy, focused on advancing cancer care through sustainable, outcome-driven and cost-efficient treatment solutions. With around 4,500 employees and offices in more than 40 countries, the company develops technologies and services that support global access to high-quality oncology treatments and is listed on Nasdaq Stockholm.
Average Trading Volume: 1,315,200
Technical Sentiment Signal: Sell
Current Market Cap: SEK21.49B
See more insights into EKTA.B stock on TipRanks’ Stock Analysis page.